Evidence map›Paper›PMID 34276302›Full record

ArticleFrontiers in molecular neuroscience2021

Inhibition of AKT Signaling Alters βIV Spectrin Distribution at the AIS and Increases Neuronal Excitability.

Jessica Di Re, Wei-Chun J Hsu, Cihan B Kayasandik, Nickolas Fularczyk, T F James, Miroslav N Nenov, Pooran Negi, Mate Marosi, Federico Scala, Saurabh Prasad and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases.International journal of molecular sciences · 2022
    Review
  4. Inhibition of the Akt/PKB Kinase Increases NaInternational journal of molecular sciences · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Jessica Di ReDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States.
Wei-Chun J HsuDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States.
Cihan B KayasandikDepartment of Mathematics, University of Houston, Houston, TX, United States.
Nickolas FularczykDepartment of Mathematics, University of Houston, Houston, TX, United States.
T F JamesDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States.
Miroslav N NenovDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States.
Pooran NegiDepartment of Mathematics, University of Houston, Houston, TX, United States.
Mate MarosiDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States.
Federico ScalaDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States.
Saurabh PrasadDepartment of Electrical and Computer Engineering, University of Houston, Houston, TX, United States.
Demetrio LabateDepartment of Mathematics, University of Houston, Houston, TX, United States.
Fernanda LaezzaDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States.
The University of Texas Medical Branch at Galveston · USUniversity of Houston · US

Funding

Molecular Mechanisms of Environmental InjuryT32ES007254 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI AMEREDES, BILL T · 1990 to 2022
$6.6M
Neurotrophin-dependent regulation of voltage-gated sodium channelsR01MH124351 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAEZZA, FERNANDA · 2020 to 2024
$3.0M
Neurotoxicology of deltamethrin in the developing brainR01ES031823 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GREEN, THOMAS ARTHUR, LAEZZA, FERNANDA · 2020 to 2024
$2.8M
Validation of FGF14 as a New Molecular Target of GSK3R01MH095995 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAEZZA, FERNANDA · 2012 to 2016
$1.9M
NIEHS NIH HHS R01 ES031823NIEHS NIH HHS T32 ES007254NIMH NIH HHS R01 MH095995NIMH NIH HHS R01 MH124351
6 · The paper itself

Abstract

The axon initial segment (AIS) is a highly regulated subcellular domain required for neuronal firing. Changes in the AIS protein composition and distribution are a form of structural plasticity, which powerfully regulates neuronal activity and may underlie several neuropsychiatric and neurodegenerative disorders. Despite its physiological and pathophysiological relevance, the signaling pathways mediating AIS protein distribution are still poorly studied. Here, we used confocal imaging and whole-cell patch clamp electrophysiology in primary hippocampal neurons to study how AIS protein composition and neuronal firing varied in response to selected kinase inhibitors targeting the AKT/GSK3 pathway, which has previously been shown to phosphorylate AIS proteins. Image-based features representing the cellular pattern distribution of the voltage-gated Na+ (Nav) channel, ankyrin G, βIV spectrin, and the cell-adhesion molecule neurofascin were analyzed, revealing βIV spectrin as the most sensitive AIS protein to AKT/GSK3 pathway inhibition. Within this pathway, inhibition of AKT by triciribine has the greatest effect on βIV spectrin localization to the AIS and its subcellular distribution within neurons, a phenotype that Support Vector Machine classification was able to accurately distinguish from control. Treatment with triciribine also resulted in increased excitability in primary hippocampal neurons. Thus, perturbations to signaling mechanisms within the AKT pathway contribute to changes in βIV spectrin distribution and neuronal firing that may be associated with neuropsychiatric and neurodegenerative disorders.

Indexed as

AIS plasticityconfocal imagingGSK3 – glycogen synthase kinase 3patch clamp electrophysiologysupport vector machine classificationWEE1 kinase

Identifiers

PMID34276302
PMCPMC8278006
OpenAlexW3174552183

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.